Immunohistochemical Expression of c-erbB2, c-erbB3 and c-erbB4 Protein in Breast Cancer
Journal of Korean Breast Cancer Society · 1998
DOI: 10.4048/jkbcs.1998.1.2.215 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Korean Breast Cancer Society, 1998. Verfasst von Kyong Sik Lee und 7 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Breast cancer is the third leading cause of cancer related deaths in Korean women. Members of the erhB receptor family, the EGF receptor and c-erbB2, c-erbB3 and c-erbB4. are commonly over-expressed in human breast cancer and there is a high correlation with an aggressive breast cancer phenotype and poor patient prognosis. Since the over~expression of the EGF receptor and c-erbB2 suggested that signalling of erbB receptors may contribute to the development and progression of breast cancer, we investigated the correlation of clinicopathological factors and the immunohistochemical expression of c-erbB2, c-erhB3 and c-erbB4. To detennine the c-erhB immunoreactivity, we used Rabbit anti-human c-erbB2 oncoprotein (DAKO, Denmark), mouse monoclonal c-erbB3(RTJ.2, Santa Cruz) and rabbit polyclonal antibody c-erbB4(Santa Cruz) directed against each c-erbB protein by immunohistochemistry from paraffin-embedded tissue in a series of 190 women with breast cancer. About 25.8%(49 out of 190 patients) of breast cancers overexpressed c-erbB2, and 40.0%(76 out of 190 patients) and 18.9%(36 out of 190 palieuts) overexpressed c-erbB3 and c-erbB4, respectively. Poor histologic grade showed tendency of positive correlation of the positivity of c-erbB2 and 3 but without statistical significance and no correlation with c-erbB4. We observed positive correlations among c-erbB2, c-erhB3 and c-erbB4 expression.(p O.05) and lymph node status(p>O.05) were not related with c-erbB family expression. The expressions of c-erbB2, c-erbB3 and c-erbB4 showed no survival benefit or no disease free benefit compared to c-erhB family negativity in univariate analysis (Kaplan-Meier life table analysis). Our results suggest that c-erbB2, c-erbB3 and c-erbB4 may regulate the growth of breast cancer by the interactions of these family of growth factor receptor that are dependent of honnonal control. (Korean J of Breast Cancer 1998;1:215.......225)
Zitieren
APA
Lee, K. S., Koo, J. Y., Chung, H. C., Suh, C. O., Lee, H. D., Lee, B. C., Jung, W. H., & Yang, W. I. (1998). Immunohistochemical Expression of c-erbB2, c-erbB3 and c-erbB4 Protein in Breast Cancer. Journal of Korean Breast Cancer Society. https://doi.org/10.4048/jkbcs.1998.1.2.215
Vancouver
Lee KS, Koo JY, Chung HC, Suh CO, Lee HD, Lee BC, et al. Immunohistochemical Expression of c-erbB2, c-erbB3 and c-erbB4 Protein in Breast Cancer. Journal of Korean Breast Cancer Society. 1998. doi:10.4048/jkbcs.1998.1.2.215
BibTeX
@article{Lee1998,
author = {Lee, Kyong Sik and Koo, Ja Yun and Chung, Hyun Cheol and Suh, Chang Ok and Lee, Hy De and Lee, Byung Chan and Jung, Woo Hee and Yang, Woo Ick},
title = {Immunohistochemical Expression of c-erbB2, c-erbB3 and c-erbB4 Protein in Breast Cancer},
journal = {Journal of Korean Breast Cancer Society},
year = {1998},
doi = {10.4048/jkbcs.1998.1.2.215}
}
EUVIMED